Application Note: Achieving data integrity through STARLIMS standalone scientific data management system
4 February 2021

More and more the FDA is issuing warning letters as a result of laboratories not following current Good Documentation Practices (GDP). A lack of data integrity can lead to facility shutdown, import bans, recalls, lawsuits, and a drop in brand value and market share. 

In this white paper, STARLIMS demonstrates how you can achieve compliance with the data integrity expectations of the Food and Drug Administration (FDA) as well as other regulatory authorities by utilizing a standalone version of STARLIMS Scientific Data Management System.